GeoVax to Present at the Noble Capital Markets Emerging Growth Equity Conference December 3, 2024. Video webcast available the following day on https://t.co/4liPYrG6eS #mpox#immunocompromised#mva
GeoVax’s collaborations with WHO, BARDA, and other stakeholders are expected to continue to drive global distribution, anticipating growth from its cancer and infectious disease portfolio through clinical milestones and partnerships. Read more. https://t.co/E10olE5GjP
Have a question about the state of an #Mpoxvaccine ? $GOVX GeoVax Labs to Present at the Emerging Growth Conference on August 21, 2024
[email protected]
The study emphasizes the importance of considering both arms of the immune system in assessing vaccine immunogenicity, particularly in the context of immunodeficiency. #vaccines#COVID19#immunocompromised#MVA $GOVX https://t.co/3g62Oa0czJ
Innovators & Investors Come Together to Shape the Future of Healthcare. #biotech, #demy-colton, #innovators, #disruptors#BioFuture2023 Learn more and register here. https://t.co/KHbA4pXe5n
Skin Rejuvenation and Resurfacing. There are so many great options for skin regeneration in chronic care as well as esthetics. $RECEL
https://t.co/FGgINgWBTT